# Evaluate the Efficacy and Safety of Rosuvastatin Versus Simvastatin in Type 2 Diabetic Patients With Dyslipidemia

> **NCT00506961** · PHASE4 · COMPLETED · sponsor: **Taipei Veterans General Hospital, Taiwan** · enrollment: 90 (actual)

## Conditions studied

- Diabetes Mellitus
- Dyslipidemia

## Interventions

- **DRUG:** Rosuvastatin
- **DRUG:** Simvastatin

## Key facts

- **NCT ID:** NCT00506961
- **Lead sponsor:** Taipei Veterans General Hospital, Taiwan
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2007-07
- **Final completion:** 2007-07
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2011-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00506961

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00506961, "Evaluate the Efficacy and Safety of Rosuvastatin Versus Simvastatin in Type 2 Diabetic Patients With Dyslipidemia". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00506961. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*